Data / Form D filings / Gemina Laboratories Ltd.
Gemina Laboratories Ltd.: Form D filings
Gemina Laboratories Ltd., a biotechnology company in Burnaby, British Columbia, Canada, filed 2 Form D notices with the SEC between 2022 and 2024. The latest, on April 1, 2024, reports $302,784 sold of a $302,784 offering to 2 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3600 Gilmore Way, Suite 302, Burnaby, British Columbia, Canada, V5G 4
- Phone
- (604) 763-3191
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- British Columbia, Canada
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1940016
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 1, 2024 | New notice | $302,784 | $302,784 | 2 | Mar 18, 2024 | sec.gov | |
| Aug 8, 2022 | New notice | $864,266 | $370,400 | $493,866 | 3 | Jul 11, 2022 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Rob Greene | Director, Executive Officer | |
| Martha Najib | Director | |
| Brian Firth | Director, Executive Officer | |
| John Davies | Director | |
| Michael Liggett | Executive Officer | |
| Martin Cronin | Director | |
| Bola Grace | Director |
Every Form D from the week of Apr 1, 2024 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Gemina Laboratories Ltd. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.